Having trouble accessing articles? Reset your cache.

Onglyza saxagliptin regulatory update

Otsuka and Kyowa Hakko Kirin said Japan approved Onglyza saxagliptin to treat Type II

Read the full 143 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE